STOCK TITAN

Molecular Partners (MOLN) Net Income by Year

MOLN NASDAQ

Molecular Partners AG reported a net loss of $77.7M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Molecular Partners AG has filed alongside them.

FY2025 annual
Net Income -$77.7M
YoY n/m
5Y CAGR n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MOLN Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-F
Net Income-$77.7Mn/m-$59.6Mn/m-$73.7M-157.8%$127.5Mn/m-$69.7Mn/m-$71.0Mn/m-$37.5M

MOLN Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'246-KQ4'2320-FQ2'236-KQ4'2220-FQ2'226-KQ4'2120-FQ4'2020-F
Net IncomeN/A-$25.7Mn/mN/A-$16.8Mn/mN/A-$17.9Mn/mN/A-$4.7MN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Molecular Partners AG financials

Frequently Asked Questions

Molecular Partners AG reported a net loss of $77.7M in fiscal year 2025.

Molecular Partners AG (MOLN) reported a $59.6M net loss in fiscal year 2024 and a $77.7M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 7 fiscal years this page covers, Molecular Partners AG (MOLN) net income went from -$37.5M in fiscal year 2019 to -$77.7M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Molecular Partners AG (MOLN) reported on that line in every period on record.